INCYTE CORPORATION Total Assets
INCYTE CORPORATION (INCY) had Total Assets of $7.34 billion as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-04-28
- 2026-03-31: Assets $7.34B.
- 2025-12-31: Assets $6.96B.
- 2025-09-30: Assets $6.33B.
- 2025-06-30: Assets $5.82B.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-03-31 | $7.34B 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $6.96B 10-Q · filed 2026-04-28 | |
| 2025-09-30 | $6.33B 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $5.82B 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $5.75B 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $5.44B 10-K · filed 2026-02-10 | |
| 2024-09-30 | $5.01B 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $4.66B 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $7.14B 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $6.78B 10-K · filed 2025-02-10 | |
| 2023-09-30 | $6.39B 10-Q · filed 2023-10-31 | |
| 2023-06-30 | $6.21B 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $5.80B 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $5.84B 10-K · filed 2024-02-13 | |
| 2022-09-30 | $5.51B 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $5.32B 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $5.05B 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $4.93B 10-K · filed 2023-02-07 | |
| 2021-09-30 | $4.20B 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $3.90B 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $3.66B 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $3.56B 10-K · filed 2022-02-08 | |
| 2020-09-30 | $3.31B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $3.21B 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $2.75B 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $3.43B 10-K · filed 2021-02-09 | |
| 2019-09-30 | $3.21B 10-Q · filed 2019-10-29 | |
| 2019-06-30 | $2.95B 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $2.75B 10-Q · filed 2019-04-30 | |
| 2018-12-31 | $2.65B 10-K · filed 2020-02-13 | |
| 2018-09-30 | $2.52B 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $2.40B 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $2.31B 10-Q · filed 2018-05-01 | |
| 2017-12-31 | $2.30B 10-K · filed 2019-02-14 | |
| 2017-09-30 | $2.37B 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $1.64B 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $1.61B 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $1.64B 10-K · filed 2018-02-15 | |
| 2016-09-30 | $1.54B 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $1.42B 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.10B 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $1.01B 10-K · filed 2017-02-14 | |
| 2015-09-30 | $931.93M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $930.34M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $862.62M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $796.48M 10-K · filed 2016-02-12 | $830.07M 10-K · filed 2015-02-17 |
| 2014-09-30 | $785.26M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $679.11M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $666.83M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $629.57M 10-K · filed 2015-02-17 | |
| 2013-09-30 | $357.40M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $334.22M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $330.28M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $330.42M 10-K · filed 2014-02-21 | |
| 2012-09-30 | $296.54M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $311.97M 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $293.59M 10-Q · filed 2012-04-26 | |
| 2011-12-31 | $328.96M 10-K · filed 2013-02-21 | |
| 2011-09-30 | $371.22M 10-Q · filed 2011-10-27 | |
| 2011-06-30 | $416.66M 10-Q · filed 2011-07-28 | |
| 2011-03-31 | $459.61M 10-Q · filed 2011-05-03 | |
| 2010-12-31 | $489.58M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |